Baxter International Inc., commonly referred to as Baxter, is a leading global healthcare company headquartered in the United States. Founded in 1931, Baxter has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices and pharmaceuticals industry, focusing on critical care, renal care, and surgical products. Baxter is renowned for its innovative core products, such as intravenous (IV) solutions, dialysis equipment, and surgical instruments, which are designed to enhance patient outcomes and streamline healthcare delivery. With a commitment to quality and safety, Baxter has achieved significant milestones, including advancements in renal therapies and the development of cutting-edge infusion systems. As a trusted partner in healthcare, Baxter continues to maintain a strong market position, recognised for its dedication to improving patient care worldwide.
How does Baxter's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Baxter's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Baxter International Inc. reported total greenhouse gas emissions of approximately 4.03 billion kg CO2e. This figure includes 352 million kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 0 kg CO2e from Scope 2 emissions, which relate to indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, approximately 3.44 billion kg CO2e, fall under Scope 3, which includes all other indirect emissions in the value chain. Baxter has set ambitious climate commitments, aiming for carbon neutrality in its direct operations by 2040. The company plans to reduce absolute Scope 1 and 2 greenhouse gas emissions by 25% by 2030, using 2020 as the base year. This target aligns with a well-below 2°C science-based target, demonstrating Baxter's commitment to addressing climate change effectively. The company has previously achieved a 45% reduction in greenhouse gas emissions indexed to revenue from 2005 to 2015, showcasing its ongoing efforts to improve sustainability. Baxter's initiatives reflect a proactive approach to environmental responsibility, with a focus on transparency and strong disclosure practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 781,365,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Baxter's Scope 3 emissions, which decreased by 10% last year and decreased by approximately 7% since 2009, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 45% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Baxter has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

